Gara Jalqabaatti › Burkitt Lymphoma › Texas › Dallas

Qorannoo klinikaalii Burkitt Lymphoma Dallas, TX keessatti

Qorannoo 7 Burkitt Lymphoma f Dallas fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Namoota walitti qabaa jiraSadarkaa 2

Medical City Dallas Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas

366 Days – 46 Years · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Namoota walitti qabaa jiraSadarkaa 2

Medical City Dallas Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas

365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Namoota walitti qabaa jiraSadarkaa 1

Baylor University Medical Center, Dallas

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT03666000

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Namoota walitti qabaa jiraSadarkaa 2

Medical City Dallas Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Namoota walitti qabaa jiraSadarkaa 3

Medical City Dallas Hospital, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas

365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Namoota walitti qabaa jiraSadarkaa 2

University of Texas, Southwestern, Dallas

Umuriin 7 hanga 25 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT05082519

Study of SGR-1505 in Mature B-Cell Neoplasms

Namoota walitti qabaa jiraSadarkaa 1

University of Texas Southwestern, Dallas

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT05544019

Qorannoo Burkitt Lymphoma magaalota biroo keessatti

Qorannoo biroo Dallas keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.